Non-thalassemia |
166 |
47.4 |
Heterozygous Hb E |
60 |
17.1 |
Heterozygous α+-thalassemia (-α3.7) |
40 |
11.4 |
Double heterozygous α+-thalassemia (-α3.7) with Hb E |
20 |
5.7 |
Heterozygous Hb Constant Spring |
12 |
3.4 |
Homozygous Hb E |
10 |
2.9 |
Heterozygous α+-thalassemia (-α3.7) with homozygous Hb E |
8 |
2.3 |
Double heterozygous α0-thalassemia (--SEA) with Hb E |
5 |
1.4 |
Homozygous α+-thalassemia (-α3.7) |
4 |
1.1 |
Heterozygous α0-thalassemia (--SEA) |
4 |
1.1 |
Double heterozygous Hb Paksé with Hb E |
3 |
0.9 |
Compound heterozygous α+-thalassemia (-α3.7) and Hb Constant Spring with Hb E |
3 |
0.9 |
Heterozygous β0-thalassemia |
2 |
0.6 |
Double heterozygous Hb Constant Spring with Hb E |
2 |
0.6 |
Heterozygous Hb Paksé |
2 |
0.6 |
Compound heterozygous α0-thalassemia (--SEA) and α+-thalassemia (-α3.7) or Hb H disease |
2 |
0.6 |
Heterozygous α-thalassemia 2 (-α4.2) |
1 |
0.3 |
Double heterozygous α+-thalassemia (-α4.2) with Hb E |
1 |
0.3 |
Homozygous α+-thalassemia (-α3.7) with heterozygous Hb E |
1 |
0.3 |
Double homozygous α+-thalassemia (-α3.7) with Hb E |
1 |
0.3 |
Compound heterozygous α+-thalassemia (-α3.7) and α+-thalassemia (-α4.2) with Hb E |
1 |
0.3 |
Compound heterozygous α+-thalassemia (-α3.7) and Hb Constant Spring |
1 |
0.3 |
Compound heterozygous α+-thalassemia (-α3.7) and Hb Constant Spring with homozygous Hb E |
1 |
0.3 |
Total |
350 |
100 |